Identification of crucial genes associated with Parkinson's disease using microarray data

Area of Science:

• Genetics
• Neuroscience
• Bioinformatics

Background:

• Parkinson's disease (PD) is a complex neurodegenerative disorder with incompletely understood genetic underpinnings.
• Identifying key genes and their regulatory networks is crucial for understanding PD pathogenesis and developing targeted therapies.

Purpose of the Study:

• To identify critical genes associated with Parkinson's disease (PD).
• To analyze the interactions and regulatory mechanisms of these identified genes.
• To validate the expression patterns of key PD-associated genes in independent datasets.

Main Methods:

• Utilized Gene Expression Omnibus (GEO) dataset (GSE7621) for differential gene expression analysis.
• Applied R software packages (Affy, Samr) for data standardization and screening of differentially expressed genes (DEGs) with FDR <0.05 and |log2FC|>1.
• Employed databases like Genetic Association Database and DAVID for predicting crucial PD genes, transcription factors (TFs), and protein-protein interactions (PPIs) using STRING.

Main Results:

• Identified 670 DEGs (398 upregulated, 272 downregulated) in PD samples.
• Pinpointed 10 DEGs crucial for PD, enriched in nervous system pathways, including C-X-C chemokine receptor type 4 (CXCR4), deleted in colorectal cancer (DCC), and NCL adaptor protein 2 (NCK2).
• Confirmed these 10 genes are involved in neuron development and differentiation, modulated by TFs (GATA, E2F, E4BP4), with DCC and CXCR4 as hub proteins. Novel interactions involving CXCR4 were identified, and CXCR4 and NCK2 upregulation was validated in an independent PD dataset (GSE8397).

Conclusions:

• The identified 10 crucial genes, their regulatory TFs, and protein-protein interactions represent significant players in Parkinson's disease progression.
• CXCR4 and NCK2 upregulation in independent datasets supports their role in PD.
• These findings provide novel molecular targets and insights into the complex mechanisms underlying Parkinson's disease.